1. Home
  2. DNTH vs ASST Comparison

DNTH vs ASST Comparison

Compare DNTH & ASST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNTH
  • ASST
  • Stock Information
  • Founded
  • DNTH 2015
  • ASST 2020
  • Country
  • DNTH United States
  • ASST United States
  • Employees
  • DNTH N/A
  • ASST N/A
  • Industry
  • DNTH Biotechnology: Pharmaceutical Preparations
  • ASST Computer Software: Prepackaged Software
  • Sector
  • DNTH Health Care
  • ASST Technology
  • Exchange
  • DNTH Nasdaq
  • ASST Nasdaq
  • Market Cap
  • DNTH 1.5B
  • ASST 1.7B
  • IPO Year
  • DNTH N/A
  • ASST 2023
  • Fundamental
  • Price
  • DNTH $34.50
  • ASST $2.14
  • Analyst Decision
  • DNTH Strong Buy
  • ASST
  • Analyst Count
  • DNTH 10
  • ASST 0
  • Target Price
  • DNTH $66.38
  • ASST N/A
  • AVG Volume (30 Days)
  • DNTH 947.1K
  • ASST 15.7M
  • Earning Date
  • DNTH 11-06-2025
  • ASST 11-13-2025
  • Dividend Yield
  • DNTH N/A
  • ASST N/A
  • EPS Growth
  • DNTH N/A
  • ASST N/A
  • EPS
  • DNTH N/A
  • ASST N/A
  • Revenue
  • DNTH $4,854,000.00
  • ASST $3,650,106.00
  • Revenue This Year
  • DNTH N/A
  • ASST N/A
  • Revenue Next Year
  • DNTH N/A
  • ASST N/A
  • P/E Ratio
  • DNTH N/A
  • ASST N/A
  • Revenue Growth
  • DNTH 17.87
  • ASST N/A
  • 52 Week Low
  • DNTH $13.37
  • ASST $0.34
  • 52 Week High
  • DNTH $40.16
  • ASST $13.42
  • Technical
  • Relative Strength Index (RSI)
  • DNTH 50.57
  • ASST 35.46
  • Support Level
  • DNTH $33.96
  • ASST $2.43
  • Resistance Level
  • DNTH $40.16
  • ASST $2.73
  • Average True Range (ATR)
  • DNTH 2.12
  • ASST 0.38
  • MACD
  • DNTH -0.97
  • ASST -0.15
  • Stochastic Oscillator
  • DNTH 4.03
  • ASST 1.95

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

About ASST Asset Entities Inc. Class B

Strive Inc is engaged in providing investment advisory, wealth management, and consulting services through its subsidiary. Its objectives is to (i) accumulate Bitcoin; (ii) increase Bitcoin-per-share; and (iii) outperform Bitcoin over the long run by deploying both beta Bitcoin treasury accumulation strategies and alpha investment strategies with the goal of beating Bitcoin's investment performance as the hurdle rate.

Share on Social Networks: